Seeta Eye Centers Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Satish Modi, M.D. at Seeta Eye Centers in Poughkeepsie, NY, is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.

Dr. Modi will be one of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.

“At Seeta Eye Centers, we are excited to begin welcoming the first patients in the IC-8 lens clinical study. We have heard wonderful things about the implant from our European Colleagues and would love to see it in general usage in the United States,” said Dr. Modi. “We are committed to educating our patients about the best vision correction solutions available, as well as participating in next-generation research.”

Seeta Eye Center is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:

• At least 22 years of age.
• Have cataracts in both eyes.
• Are available, willing and able to participate in examinations and all follow- up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Sarah Piza at Seeta Eye Centers at (845) 454-1025 ext. 116 or at [email protected].

Seeta Eye Centers has served the Hudson Valley community for more than 50 years. As the longest practicing ophthalmology group in our region, we take pride in the relationships we have established with our patients, and we make it a priority to provide our community with an unsurpassed standard of excellence in the eye care industry. www.seeta-eye-care-center.com (845) 454-1025

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of vision. The IC-8 lens received its CE mark in 2014 and is available in select markets across Europe and Asia. Founded in 2001, AcuFocus is based in Irvine, Calif. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005278/en/

Shelle Murach
Cunningham & Associates
714 206-4138
[email protected]